Invivyd (IVVD) Cash from Financing Activities (2021 - 2025)

Invivyd's (IVVD) quarterly Cash from Financing Activities came in at $157.2 million in Q4 2025, up 204025.97% YoY from N/an in Q4 2024, and up 169.54% on a QoQ basis from $58.3 million in Q3 2025.

Invivyd (IVVD) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has 5 years of Cash from Financing Activities data on file, last reported at $157.2 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 204025.97% year-over-year to $157.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $215.6 million (up 448.24% YoY) and the FY2025 annual result came in at $215.6 million, up 448.24% from the prior year.
  • Cash from Financing Activities grew to $157.2 million in Q4 2025, from $58.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $334.8 million in Q2 2021 to a low of -$749000.0 in Q4 2021.
  • A 5-year average of $48.4 million and a median of $141000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities plunged 99.98% — and 2025, when it jumped 204025.97%.
  • Tracing IVVD's Cash from Financing Activities over 5 years: stood at -$749000.0 in 2021, then surged by 118.83% to $141000.0 in 2022, then changed by 0.0% to $141000.0 in 2023, then plunged by 45.39% to $77000.0 in 2024, then jumped by 204025.97% to $157.2 million in 2025.
  • The last three Cash from Financing Activities figures came in at $157.2 million (Q4 2025), $58.3 million (Q3 2025), and $131000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Invivyd 212.23 Mn 52.15 Mn 13.01 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 157.18 Mn
Dec 31, 2025 157.18 Mn
Sep 30, 2025 58.31 Mn
Sep 30, 2025 58.31 Mn
Jun 30, 2025 131,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 10,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 77,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 61,000.00
Sep 30, 2024 61,000.00
Jun 30, 2024 92,000.00
Jun 30, 2024 92,000.00
Mar 31, 2024 39.10 Mn
Mar 31, 2024 39.10 Mn
Dec 31, 2023 141,000.00
Dec 31, 2023 141,000.00
Sep 30, 2023 92,000.00
Sep 30, 2023 92,000.00